Shivalik Rasayan Ltd · SHIVALIK · Pesticides/Agrochemicals · price as of the 18 November 2026 close, updated every trading day · results updated weekly
Shivalik Rasayan share price today: ₹291.20 at the close on 18 November 2026, down 28.1% in a year. Shivalik Rasayan (SHIVALIK) is worth ₹467 crore, trades at a P/E of 32.2 and has closed between ₹212.90 and ₹414.85 over the past 52 weeks.
Shivalik Rasayan Ltd's results are improving, while its P/E is near the low end of its own history over 11 years, higher than only 32% of past readings.
The main question: profits are rising, but only −88% of the last 3 years' profit came in as cash from operations. The gap between reported profit and actual cash is the thing to watch.
The price is in an uptrend that has just slipped below its 200-day average, and the P/E is lower than 68% of its own last 11 years. Over the last four quarters, results have been improving, with profit +25.3% on a year earlier, and −88% of the last 3 years' profit came in as cash. What will decide it: whether the cash starts to follow the profit.
Left out of this page: Its two data sources disagree by up to 31% on reported income across 15 comparable periods, so nothing from the second source is shown here. That is why the quarterly PEG curve, the yearly return-on-capital-used (ROIC) line, the total-debt and debt-to-equity series and the F-score and the return-on-capital-used (ROIC) reading are missing. When two sources disagree on a figure, we leave it out on purpose. The gap is a choice, not missing data. The quarterly history also starts where the main source starts: 5 earlier quarters from the second source are not added in front of it. Adding to a profit history needs a source that has been checked.
What is the Shivalik Rasayan share price today?
Shivalik Rasayan Ltd's share price was ₹291.20 at the close on 18 November 2026. It is in an uptrend that has just slipped below its 200-day average. That is 9.0% below its average price over the last 200 trading days.
A share price tends to move through four phases: moving sideways (stage 1), rising (stage 2), stalling near a high (stage 3) and falling (stage 4). Today Shivalik Rasayan Ltd is in stage 2. The phase helps read everything below.
In the last 52 weeks it traded between ₹213 and ₹415, and at that close it sat 39% of the way up from that low. Over the past 13 weeks it has done worse than the NIFTY 500, and it has been behind for 2 weeks running.
Week by week since 2016: did it beat the NIFTY 500 over the past 13 weeks?
Ahead in 262 of 526 weeks
| Week | 13-week return vs NIFTY 500 |
|---|---|
| 1 Apr 2016 | no NIFTY 500 reading |
| 8 Apr 2016 | no NIFTY 500 reading |
| 13 Apr 2016 | no NIFTY 500 reading |
| 22 Apr 2016 | no NIFTY 500 reading |
| 29 Apr 2016 | no NIFTY 500 reading |
| 6 May 2016 | no NIFTY 500 reading |
| 12 May 2016 | no NIFTY 500 reading |
| 20 May 2016 | no NIFTY 500 reading |
| 27 May 2016 | no NIFTY 500 reading |
| 3 Jun 2016 | no NIFTY 500 reading |
| 10 Jun 2016 | no NIFTY 500 reading |
| 15 Jun 2016 | no NIFTY 500 reading |
| 24 Jun 2016 | no NIFTY 500 reading |
| 1 Jul 2016 | +9.4% |
| 8 Jul 2016 | +1.9% |
| 15 Jul 2016 | −3.4% |
| 22 Jul 2016 | +7.4% |
| 28 Jul 2016 | +21.9% |
| 5 Aug 2016 | +65.0% |
| 12 Aug 2016 | +55.1% |
| 19 Aug 2016 | +78.7% |
| 26 Aug 2016 | +75.9% |
| 2 Sep 2016 | +73.8% |
| 9 Sep 2016 | +76.1% |
| 14 Sep 2016 | +70.1% |
| 21 Sep 2016 | +56.4% |
| 29 Sep 2016 | +67.4% |
| 7 Oct 2016 | +94.8% |
| 14 Oct 2016 | +110.9% |
| 20 Oct 2016 | +74.3% |
| 28 Oct 2016 | +57.2% |
| 4 Nov 2016 | +65.8% |
| 11 Nov 2016 | +61.1% |
| 18 Nov 2016 | +55.7% |
| 25 Nov 2016 | +45.6% |
| 2 Dec 2016 | +53.8% |
| 9 Dec 2016 | +46.8% |
| 16 Dec 2016 | +42.2% |
| 23 Dec 2016 | +45.6% |
| 30 Dec 2016 | +40.4% |
| 6 Jan 2017 | +27.1% |
| 13 Jan 2017 | +36.2% |
| 20 Jan 2017 | +39.3% |
| 27 Jan 2017 | +35.1% |
| 3 Feb 2017 | +4.2% |
| 10 Feb 2017 | −3.1% |
| 17 Feb 2017 | +4.5% |
| 23 Feb 2017 | +4.8% |
| 3 Mar 2017 | −2.4% |
| 10 Mar 2017 | +0.5% |
| 17 Mar 2017 | +5.9% |
| 24 Mar 2017 | −2.2% |
| 31 Mar 2017 | +5.9% |
| 7 Apr 2017 | +22.1% |
| 13 Apr 2017 | −1.9% |
| 21 Apr 2017 | −1.6% |
| 28 Apr 2017 | −5.5% |
| 5 May 2017 | +6.4% |
| 12 May 2017 | +6.1% |
| 19 May 2017 | +23.4% |
| 26 May 2017 | +23.9% |
| 2 Jun 2017 | +12.6% |
| 9 Jun 2017 | +12.8% |
| 16 Jun 2017 | +14.2% |
| 23 Jun 2017 | +47.7% |
| 30 Jun 2017 | +54.4% |
| 7 Jul 2017 | +25.3% |
| 14 Jul 2017 | +31.0% |
| 21 Jul 2017 | +40.8% |
| 28 Jul 2017 | +50.2% |
| 4 Aug 2017 | +41.3% |
| 11 Aug 2017 | +50.5% |
| 17 Aug 2017 | +23.1% |
| 23 Aug 2017 | +30.6% |
| 1 Sep 2017 | +44.3% |
| 8 Sep 2017 | +49.4% |
| 15 Sep 2017 | +41.8% |
| 22 Sep 2017 | +16.5% |
| 29 Sep 2017 | +8.2% |
| 6 Oct 2017 | +31.6% |
| 13 Oct 2017 | +59.9% |
| 19 Oct 2017 | +20.2% |
| 27 Oct 2017 | +28.1% |
| 3 Nov 2017 | +18.9% |
| 10 Nov 2017 | +13.7% |
| 17 Nov 2017 | +15.7% |
| 24 Nov 2017 | +13.9% |
| 1 Dec 2017 | +18.6% |
| 8 Dec 2017 | +16.7% |
| 15 Dec 2017 | +17.5% |
| 22 Dec 2017 | +20.2% |
| 29 Dec 2017 | +21.1% |
| 5 Jan 2018 | +17.0% |
| 12 Jan 2018 | +4.0% |
| 19 Jan 2018 | +32.5% |
| 25 Jan 2018 | +25.3% |
| 2 Feb 2018 | +25.7% |
| 9 Feb 2018 | +31.8% |
| 16 Feb 2018 | +28.7% |
| 23 Feb 2018 | +22.8% |
| 1 Mar 2018 | +46.5% |
| 9 Mar 2018 | +33.6% |
| 16 Mar 2018 | +39.3% |
| 23 Mar 2018 | +29.2% |
| 28 Mar 2018 | +22.9% |
| 6 Apr 2018 | +10.5% |
| 13 Apr 2018 | +0.7% |
| 20 Apr 2018 | +9.7% |
| 27 Apr 2018 | +10.2% |
| 4 May 2018 | +33.1% |
| 11 May 2018 | +22.4% |
| 18 May 2018 | +22.7% |
| 25 May 2018 | +29.7% |
| 1 Jun 2018 | −0.5% |
| 8 Jun 2018 | +16.0% |
| 15 Jun 2018 | +8.3% |
| 22 Jun 2018 | +12.9% |
| 29 Jun 2018 | +14.6% |
| 6 Jul 2018 | +8.5% |
| 13 Jul 2018 | +7.8% |
| 20 Jul 2018 | −5.3% |
| 27 Jul 2018 | −9.1% |
| 3 Aug 2018 | −21.1% |
| 10 Aug 2018 | −10.2% |
| 17 Aug 2018 | −4.2% |
| 24 Aug 2018 | −7.5% |
| 31 Aug 2018 | −3.1% |
| 7 Sep 2018 | −3.3% |
| 14 Sep 2018 | +3.5% |
| 21 Sep 2018 | +2.3% |
| 28 Sep 2018 | −0.7% |
| 5 Oct 2018 | −1.1% |
| 12 Oct 2018 | +6.7% |
| 19 Oct 2018 | +0.5% |
| 26 Oct 2018 | +0.5% |
| 2 Nov 2018 | +0.6% |
| 9 Nov 2018 | −2.2% |
| 16 Nov 2018 | −1.2% |
| 22 Nov 2018 | +4.1% |
| 30 Nov 2018 | −3.3% |
| 7 Dec 2018 | −8.7% |
| 14 Dec 2018 | −12.4% |
| 21 Dec 2018 | −13.4% |
| 28 Dec 2018 | −11.9% |
| 4 Jan 2019 | −7.1% |
| 11 Jan 2019 | −13.5% |
| 18 Jan 2019 | −10.5% |
| 25 Jan 2019 | −9.4% |
| 1 Feb 2019 | −12.0% |
| 8 Feb 2019 | −14.9% |
| 15 Feb 2019 | −23.4% |
| 22 Feb 2019 | −25.8% |
| 1 Mar 2019 | −20.4% |
| 8 Mar 2019 | −4.2% |
| 15 Mar 2019 | −5.3% |
| 22 Mar 2019 | −7.5% |
| 29 Mar 2019 | −9.4% |
| 5 Apr 2019 | −7.3% |
| 12 Apr 2019 | −1.7% |
| 18 Apr 2019 | +2.9% |
| 26 Apr 2019 | +5.7% |
| 3 May 2019 | +1.6% |
| 10 May 2019 | +1.8% |
| 17 May 2019 | +8.7% |
| 24 May 2019 | +4.9% |
| 31 May 2019 | +11.3% |
| 7 Jun 2019 | −6.4% |
| 14 Jun 2019 | −6.9% |
| 21 Jun 2019 | −8.5% |
| 28 Jun 2019 | +5.8% |
| 5 Jul 2019 | −9.1% |
| 12 Jul 2019 | −16.5% |
| 19 Jul 2019 | −25.5% |
| 26 Jul 2019 | −23.9% |
| 2 Aug 2019 | −14.0% |
| 9 Aug 2019 | −25.8% |
| 16 Aug 2019 | −24.2% |
| 23 Aug 2019 | −19.2% |
| 30 Aug 2019 | −24.8% |
| 6 Sep 2019 | −27.0% |
| 13 Sep 2019 | −21.0% |
| 20 Sep 2019 | −14.9% |
| 27 Sep 2019 | −22.3% |
| 4 Oct 2019 | −17.1% |
| 11 Oct 2019 | −17.7% |
| 18 Oct 2019 | −11.3% |
| 27 Oct 2019 | −7.4% |
| 1 Nov 2019 | −15.4% |
| 8 Nov 2019 | +14.7% |
| 15 Nov 2019 | +2.7% |
| 22 Nov 2019 | +1.4% |
| 29 Nov 2019 | +6.1% |
| 6 Dec 2019 | +10.6% |
| 13 Dec 2019 | +5.6% |
| 20 Dec 2019 | +11.4% |
| 27 Dec 2019 | +29.6% |
| 3 Jan 2020 | +30.2% |
| 10 Jan 2020 | +34.8% |
| 17 Jan 2020 | +41.5% |
| 24 Jan 2020 | +17.0% |
| 1 Feb 2020 | +16.4% |
| 7 Feb 2020 | +2.8% |
| 14 Feb 2020 | +21.9% |
| 20 Feb 2020 | +21.1% |
| 28 Feb 2020 | +38.9% |
| 6 Mar 2020 | +24.3% |
| 13 Mar 2020 | +18.9% |
| 20 Mar 2020 | +10.1% |
| 27 Mar 2020 | +2.7% |
| 3 Apr 2020 | +14.7% |
| 9 Apr 2020 | +23.8% |
| 17 Apr 2020 | +22.0% |
| 24 Apr 2020 | +34.6% |
| 30 Apr 2020 | +34.7% |
| 8 May 2020 | +29.7% |
| 15 May 2020 | +21.0% |
| 22 May 2020 | +10.9% |
| 29 May 2020 | −3.7% |
| 5 Jun 2020 | +6.4% |
| 12 Jun 2020 | +19.8% |
| 19 Jun 2020 | +30.7% |
| 26 Jun 2020 | +21.4% |
| 3 Jul 2020 | −1.3% |
| 10 Jul 2020 | +15.0% |
| 17 Jul 2020 | +14.5% |
| 24 Jul 2020 | +24.3% |
| 31 Jul 2020 | +56.4% |
| 7 Aug 2020 | +70.3% |
| 14 Aug 2020 | +69.6% |
| 21 Aug 2020 | +86.5% |
| 28 Aug 2020 | +62.8% |
| 4 Sep 2020 | +54.4% |
| 11 Sep 2020 | +38.3% |
| 18 Sep 2020 | +37.4% |
| 25 Sep 2020 | +36.5% |
| 1 Oct 2020 | +40.6% |
| 9 Oct 2020 | +12.5% |
| 16 Oct 2020 | +11.7% |
| 23 Oct 2020 | +1.8% |
| 30 Oct 2020 | −13.7% |
| 6 Nov 2020 | −22.4% |
| 14 Nov 2020 | −22.2% |
| 20 Nov 2020 | −18.6% |
| 27 Nov 2020 | −8.4% |
| 4 Dec 2020 | −11.2% |
| 11 Dec 2020 | −9.8% |
| 18 Dec 2020 | −18.9% |
| 24 Dec 2020 | −23.1% |
| 1 Jan 2021 | −10.7% |
| 8 Jan 2021 | −17.1% |
| 15 Jan 2021 | −16.4% |
| 22 Jan 2021 | −17.3% |
| 29 Jan 2021 | −5.7% |
| 5 Feb 2021 | −12.0% |
| 12 Feb 2021 | +23.8% |
| 19 Feb 2021 | +29.3% |
| 26 Feb 2021 | +45.4% |
| 5 Mar 2021 | +66.4% |
| 12 Mar 2021 | +68.0% |
| 19 Mar 2021 | +54.2% |
| 26 Mar 2021 | +50.3% |
| 1 Apr 2021 | +41.2% |
| 9 Apr 2021 | +46.1% |
| 16 Apr 2021 | +43.0% |
| 23 Apr 2021 | +47.9% |
| 30 Apr 2021 | +28.9% |
| 7 May 2021 | +43.6% |
| 14 May 2021 | +13.5% |
| 21 May 2021 | +5.3% |
| 28 May 2021 | −6.5% |
| 4 Jun 2021 | −14.5% |
| 11 Jun 2021 | −18.6% |
| 18 Jun 2021 | −10.5% |
| 25 Jun 2021 | +0.9% |
| 2 Jul 2021 | −1.7% |
| 9 Jul 2021 | +15.6% |
| 16 Jul 2021 | +26.6% |
| 23 Jul 2021 | +22.2% |
| 30 Jul 2021 | +25.8% |
| 6 Aug 2021 | +42.3% |
| 13 Aug 2021 | +27.7% |
| 20 Aug 2021 | +22.8% |
| 27 Aug 2021 | +34.5% |
| 3 Sep 2021 | +26.3% |
| 9 Sep 2021 | +23.5% |
| 17 Sep 2021 | +20.2% |
| 24 Sep 2021 | +11.5% |
| 1 Oct 2021 | +17.7% |
| 8 Oct 2021 | −0.7% |
| 14 Oct 2021 | −13.3% |
| 22 Oct 2021 | −13.0% |
| 29 Oct 2021 | −12.3% |
| 4 Nov 2021 | −22.6% |
| 12 Nov 2021 | −25.5% |
| 18 Nov 2021 | −17.5% |
| 26 Nov 2021 | −21.3% |
| 3 Dec 2021 | −12.2% |
| 10 Dec 2021 | −8.9% |
| 17 Dec 2021 | −6.5% |
| 24 Dec 2021 | +3.5% |
| 31 Dec 2021 | +5.0% |
| 7 Jan 2022 | +14.5% |
| 14 Jan 2022 | +17.4% |
| 21 Jan 2022 | +11.2% |
| 28 Jan 2022 | +12.8% |
| 4 Feb 2022 | +4.4% |
| 11 Feb 2022 | +9.6% |
| 18 Feb 2022 | +4.1% |
| 25 Feb 2022 | +7.4% |
| 4 Mar 2022 | +2.5% |
| 11 Mar 2022 | +1.8% |
| 17 Mar 2022 | +4.4% |
| 25 Mar 2022 | −8.2% |
| 1 Apr 2022 | −10.7% |
| 8 Apr 2022 | −11.4% |
| 13 Apr 2022 | −11.6% |
| 22 Apr 2022 | −2.4% |
| 29 Apr 2022 | −9.4% |
| 6 May 2022 | −2.5% |
| 13 May 2022 | −9.1% |
| 20 May 2022 | −7.0% |
| 27 May 2022 | −13.0% |
| 3 Jun 2022 | −9.8% |
| 10 Jun 2022 | −6.9% |
| 17 Jun 2022 | −12.2% |
| 24 Jun 2022 | −8.4% |
| 1 Jul 2022 | −13.5% |
| 8 Jul 2022 | −15.4% |
| 15 Jul 2022 | −15.6% |
| 22 Jul 2022 | −16.1% |
| 29 Jul 2022 | −10.2% |
| 5 Aug 2022 | −8.1% |
| 12 Aug 2022 | −7.2% |
| 19 Aug 2022 | +4.4% |
| 26 Aug 2022 | +34.7% |
| 2 Sep 2022 | +16.6% |
| 9 Sep 2022 | +6.9% |
| 16 Sep 2022 | +6.6% |
| 23 Sep 2022 | +8.4% |
| 30 Sep 2022 | +6.0% |
| 7 Oct 2022 | +5.4% |
| 14 Oct 2022 | +5.9% |
| 21 Oct 2022 | +1.3% |
| 28 Oct 2022 | −2.4% |
| 4 Nov 2022 | −9.1% |
| 11 Nov 2022 | −2.8% |
| 18 Nov 2022 | −11.6% |
| 25 Nov 2022 | −32.6% |
| 2 Dec 2022 | −31.1% |
| 9 Dec 2022 | −23.5% |
| 16 Dec 2022 | −12.5% |
| 23 Dec 2022 | −21.5% |
| 30 Dec 2022 | −12.3% |
| 6 Jan 2023 | −16.3% |
| 13 Jan 2023 | −12.8% |
| 20 Jan 2023 | −14.8% |
| 27 Jan 2023 | −12.7% |
| 3 Feb 2023 | −15.5% |
| 10 Feb 2023 | −5.3% |
| 17 Feb 2023 | −11.7% |
| 24 Feb 2023 | −4.9% |
| 3 Mar 2023 | +1.8% |
| 10 Mar 2023 | −6.1% |
| 17 Mar 2023 | −9.8% |
| 24 Mar 2023 | +0.7% |
| 31 Mar 2023 | −5.9% |
| 6 Apr 2023 | +8.0% |
| 13 Apr 2023 | +10.9% |
| 21 Apr 2023 | +12.8% |
| 28 Apr 2023 | +8.4% |
| 5 May 2023 | +7.8% |
| 12 May 2023 | −4.7% |
| 19 May 2023 | −3.0% |
| 26 May 2023 | +2.0% |
| 2 Jun 2023 | +6.4% |
| 9 Jun 2023 | +8.3% |
| 16 Jun 2023 | +9.0% |
| 23 Jun 2023 | +3.9% |
| 30 Jun 2023 | +4.7% |
| 7 Jul 2023 | −11.1% |
| 14 Jul 2023 | −18.5% |
| 21 Jul 2023 | −16.0% |
| 28 Jul 2023 | −8.7% |
| 4 Aug 2023 | +7.9% |
| 11 Aug 2023 | +1.0% |
| 18 Aug 2023 | +0.6% |
| 25 Aug 2023 | −3.6% |
| 1 Sep 2023 | −8.7% |
| 8 Sep 2023 | −13.0% |
| 15 Sep 2023 | −16.3% |
| 22 Sep 2023 | −17.6% |
| 29 Sep 2023 | −11.2% |
| 6 Oct 2023 | −11.0% |
| 13 Oct 2023 | −10.1% |
| 20 Oct 2023 | −10.5% |
| 27 Oct 2023 | −10.5% |
| 3 Nov 2023 | −20.2% |
| 12 Nov 2023 | −19.7% |
| 17 Nov 2023 | −16.3% |
| 24 Nov 2023 | −17.3% |
| 1 Dec 2023 | −16.0% |
| 8 Dec 2023 | −17.8% |
| 15 Dec 2023 | −22.2% |
| 22 Dec 2023 | −21.8% |
| 29 Dec 2023 | −12.6% |
| 5 Jan 2024 | −14.4% |
| 12 Jan 2024 | −16.1% |
| 20 Jan 2024 | −13.0% |
| 25 Jan 2024 | −18.5% |
| 2 Feb 2024 | −18.7% |
| 9 Feb 2024 | −13.6% |
| 16 Feb 2024 | −12.1% |
| 23 Feb 2024 | −20.6% |
| 1 Mar 2024 | −25.8% |
| 7 Mar 2024 | −16.0% |
| 15 Mar 2024 | −17.2% |
| 22 Mar 2024 | −12.8% |
| 28 Mar 2024 | −26.3% |
| 5 Apr 2024 | −23.0% |
| 12 Apr 2024 | −17.4% |
| 19 Apr 2024 | −23.6% |
| 26 Apr 2024 | −22.5% |
| 3 May 2024 | −12.9% |
| 10 May 2024 | −11.3% |
| 18 May 2024 | −14.4% |
| 24 May 2024 | −13.5% |
| 31 May 2024 | −4.0% |
| 7 Jun 2024 | −9.1% |
| 14 Jun 2024 | −4.5% |
| 21 Jun 2024 | −5.5% |
| 28 Jun 2024 | −1.7% |
| 5 Jul 2024 | +13.3% |
| 12 Jul 2024 | +4.0% |
| 19 Jul 2024 | −1.0% |
| 26 Jul 2024 | +1.1% |
| 2 Aug 2024 | −9.6% |
| 9 Aug 2024 | −15.5% |
| 16 Aug 2024 | −21.0% |
| 23 Aug 2024 | −8.7% |
| 30 Aug 2024 | −18.7% |
| 6 Sep 2024 | −13.9% |
| 13 Sep 2024 | −12.2% |
| 20 Sep 2024 | −19.5% |
| 27 Sep 2024 | −14.7% |
| 4 Oct 2024 | −15.4% |
| 11 Oct 2024 | −15.3% |
| 18 Oct 2024 | −12.6% |
| 25 Oct 2024 | −14.6% |
| 1 Nov 2024 | −6.7% |
| 8 Nov 2024 | −5.2% |
| 14 Nov 2024 | +2.6% |
| 22 Nov 2024 | −0.5% |
| 29 Nov 2024 | +9.2% |
| 6 Dec 2024 | +43.1% |
| 13 Dec 2024 | +46.5% |
| 20 Dec 2024 | +54.7% |
| 27 Dec 2024 | +36.3% |
| 3 Jan 2025 | +23.3% |
| 10 Jan 2025 | +24.3% |
| 17 Jan 2025 | +44.1% |
| 24 Jan 2025 | +51.6% |
| 1 Feb 2025 | +42.1% |
| 7 Feb 2025 | +40.9% |
| 14 Feb 2025 | +28.3% |
| 21 Feb 2025 | +38.1% |
| 28 Feb 2025 | +35.7% |
| 7 Mar 2025 | −1.5% |
| 13 Mar 2025 | −10.0% |
| 21 Mar 2025 | −16.4% |
| 28 Mar 2025 | −12.7% |
| 4 Apr 2025 | −8.6% |
| 11 Apr 2025 | −10.3% |
| 17 Apr 2025 | −21.3% |
| 25 Apr 2025 | −27.4% |
| 2 May 2025 | −30.5% |
| 9 May 2025 | −27.0% |
| 16 May 2025 | −19.9% |
| 23 May 2025 | −28.5% |
| 30 May 2025 | −33.1% |
| 6 Jun 2025 | −32.0% |
| 13 Jun 2025 | −23.8% |
| 20 Jun 2025 | −23.3% |
| 27 Jun 2025 | −24.1% |
| 4 Jul 2025 | −28.2% |
| 11 Jul 2025 | −23.5% |
| 18 Jul 2025 | −9.3% |
| 25 Jul 2025 | −12.0% |
| 1 Aug 2025 | +0.2% |
| 8 Aug 2025 | −2.9% |
| 14 Aug 2025 | −9.9% |
| 22 Aug 2025 | −16.1% |
| 29 Aug 2025 | −20.5% |
| 5 Sep 2025 | −16.9% |
| 12 Sep 2025 | −13.3% |
| 19 Sep 2025 | −11.9% |
| 26 Sep 2025 | −15.5% |
| 3 Oct 2025 | −15.8% |
| 10 Oct 2025 | −18.2% |
| 17 Oct 2025 | −33.1% |
| 24 Oct 2025 | −27.6% |
| 31 Oct 2025 | −29.8% |
| 7 Nov 2025 | −22.0% |
| 14 Nov 2025 | −21.9% |
| 21 Nov 2025 | −21.9% |
| 28 Nov 2025 | −18.7% |
| 5 Dec 2025 | −18.7% |
| 12 Dec 2025 | −24.4% |
| 19 Dec 2025 | −25.3% |
| 26 Dec 2025 | −20.1% |
| 2 Jan 2026 | −22.1% |
| 9 Jan 2026 | −19.4% |
| 16 Jan 2026 | −18.6% |
| 23 Jan 2026 | −19.4% |
| 1 Feb 2026 | −29.0% |
| 6 Feb 2026 | −36.9% |
| 13 Feb 2026 | −33.5% |
| 20 Feb 2026 | −24.2% |
| 27 Feb 2026 | −25.8% |
| 6 Mar 2026 | −22.9% |
| 13 Mar 2026 | −20.7% |
| 20 Mar 2026 | −24.9% |
| 27 Mar 2026 | −25.6% |
| 14 Aug 2026 | −24.4% |
| 21 Aug 2026 | −22.4% |
| 28 Aug 2026 | −5.6% |
| 4 Sep 2026 | +1.9% |
| 11 Sep 2026 | +20.7% |
| 18 Sep 2026 | +32.5% |
| 25 Sep 2026 | +49.9% |
| 28 Sep 2026 | +41.6% |
| 1 Oct 2026 | +43.0% |
| 9 Oct 2026 | +29.6% |
| 16 Oct 2026 | +26.9% |
| 23 Oct 2026 | +30.3% |
| 30 Oct 2026 | +24.8% |
| 6 Nov 2026 | +20.2% |
| 8 Nov 2026 | +23.8% |
| 13 Nov 2026 | −3.2% |
| 18 Nov 2026 | −13.4% |
Over the last 11 years the share price moved +860% while the NIFTY 500 moved +268%, so it is ahead of the index over that whole period. It was last ahead over 13 weeks in the week of 8 November 2026. The chart above shows the 13-week comparison for every week.
This page treats a rise as over when the price closes below its 200-day average on two Fridays in a row.
What are Shivalik Rasayan's latest quarterly results?
For July to September 2026 (the quarter ended 30 September 2026), Shivalik Rasayan reported revenue of ₹101 crore, up 7.2% from ₹93.8 crore a year earlier, and a profit of ₹5.40 crore, up 25.3% from ₹4.31 crore.
Shivalik Rasayan results: July to September 2026 against a year earlier
| Measure | July to September 2026 | July to September 2025 | Change |
|---|---|---|---|
| Revenue | ₹101 crore | ₹93.8 crore | +7.2% |
| Profit | ₹5.40 crore | ₹4.31 crore | +25.3% |
| Earnings per share | ₹2.30 | ₹1.94 | +18.6% |
| Operating margin | 14.7% | 12.8% | +1.9 points |
The next results, for October to December 2026, are due by 14 February 2027: listed companies must publish quarterly results within 45 days of the quarter's end (60 days for the January to March quarter).
From the company's reported quarterly results (quarter ended 30 September 2026). Revenue and profit in ₹ crore.
What is the Shivalik Rasayan share price history?
Shivalik Rasayan closed at ₹291.20 on 18 November 2026, down 28.1% from ₹405.05 a year earlier (21 November 2025) and down 67.2% over five years. Its highest weekly close since April 2016 was ₹1,125.45 on 7 January 2022.
Shivalik Rasayan share price: then and now
| When | Close | Change to 18 Nov 2026 |
|---|---|---|
| 1 week ago · 11 Nov 2026 | ₹305.75 | −4.8% |
| 1 month ago · 19 Oct 2026 | ₹326.30 | −10.8% |
| 1 year ago · 21 Nov 2025 | ₹405.05 | −28.1% |
| 3 years ago · 17 Nov 2023 | ₹656.75 | −55.7% |
| 5 years ago · 18 Nov 2021 | ₹886.85 | −67.2% |
| 10 years ago · 18 Nov 2016 | ₹92.52 | +214.7% |
| Earliest and lowest weekly close in our records · 1 Apr 2016 | ₹30.34 | +859.8% |
| Highest weekly close since April 2016 · 7 Jan 2022 | ₹1,125.45 | −74.1% |
| 52-week high (weekly close) · 28 Sep 2026 | ₹414.85 | −29.8% |
| 52-week low (weekly close) · 25 Jun 2026 | ₹212.90 | +36.8% |
Weekly closing prices. Each change is the move from that price to the 18 Nov 2026 close. A day's intraday high or low can go beyond these weekly closes.
539 weekly closes from 1 April 2016 to 18 November 2026.
What is the latest news on Shivalik Rasayan?
18 Nov 2026: Shivalik Rasayan closed at ₹291.20, down 4.8% on the week and down 10.8% on the month. Results for July to September 2026: Revenue up 7.2% and profit up 25.3% on a year earlier.
Earlier
- 21 Sep 2026: ex-date for a dividend of ₹0.50 a share.
What dividend does Shivalik Rasayan pay?
Shivalik Rasayan paid ₹0.50 a share in regular dividends in the 12 months to 18 November 2026 (1 payment), a yield of 0.17% at the ₹291.20 close on 18 November 2026. The last was a dividend of ₹0.50 a share, ex-date 21 September 2026.
Shivalik Rasayan dividends since 1 April 2021
| Ex-date | Dividend per share | Type | Record date |
|---|---|---|---|
| 21 Sep 2026Dividend | ₹0.50 | Dividend | same day |
| 19 Sep 2025Dividend | ₹0.50 | Dividend | 20 Sep 2025 |
| 20 Sep 2024Dividend | ₹0.50 | Dividend | — |
| 22 Sep 2023Dividend | ₹0.50 | Dividend | — |
| 21 Sep 2022Dividend | ₹0.50 | Dividend | — |
Amounts as the company declared them on the exchange. A dividend goes to whoever owns the shares before the ex-date.
Yes. Shivalik Rasayan Ltd paid out 6% of its profit as dividends in FY26, and it paid a dividend in 10 of its last 12 reported years.
From the exchange corporate-actions record, read 18 November 2026.
What to watch in Shivalik Rasayan's next results?
When Shivalik Rasayan reports October to December 2026, these are the 4 checks that show whether the story is still on course. First: Revenue against the same quarter a year earlier.
- Revenue against the same quarter a year earlier. In the Sep 2026 quarter, revenue was +7.2% on a year earlier, and the last four quarters averaged +14.9%.
- Whether the operating margin stays near 14.7%. It is 1.9 percentage points higher than four quarters earlier.
- Net profit against the same quarter a year earlier. In the Sep 2026 quarter, profit was +25.3% on a year earlier. It has grown on a year earlier for 3 quarters in a row.
- Whether cash from operations catches up with profit. Only −88% of the last 3 years' profit came in as cash from operations.
Which stock lists is Shivalik Rasayan on?
Shivalik Rasayan is not on any of our India lists this week.
Is Shivalik Rasayan profitable?
Shivalik Rasayan Ltd earned ₹5.4 Cr of net profit in the Sep 2026 quarter, +25.3% on the same quarter a year earlier. That is the 3rd quarter in a row of profit growth. Full-year FY26 profit was ₹18.0 Cr. Over 10 years profit has grown 19.6% a year on average. The same quarter a year earlier earned ₹4.3 Cr.
Net profit is what is left after every cost, interest and tax. Earnings per share, dividends and book value all grow from it.
The Sep 2026 quarter's profit is 5.4% of that quarter's revenue.
For the full year, FY26 profit was ₹18.0 Cr (−18.2% on the year before).
Why profit moved: revenue changed +7.2% on a year earlier and the margin moved +1.9 percentage points. Sales did the work, and the margin was about flat.
On average over the last four quarters, profit changed +19.0% and revenue +14.9%. Profit is growing faster than sales: fixed costs are spread over more sales, so each extra rupee of revenue adds more to profit.
How much revenue does Shivalik Rasayan make, and is it growing?
Shivalik Rasayan Ltd reported ₹101 Cr of revenue in the Sep 2026 quarter, +7.2% on the same quarter a year earlier. That is the 3rd quarter in a row with growth on the year before. Over 10 years it has grown 12.8% a year on average. The last full year, FY26, came in at ₹368 Cr.
Revenue is everything the company billed its customers in the period.
The last four reported quarters add to ₹382 Cr.
FY26 revenue was ₹368 Cr, +17.9% on the year before.
Recent pace: the last four quarters grew +14.9% on average, against 12.8% a year over the longer run, so this year is growing faster than its own long-run rate.
Is growth speeding up? Revenue over the last 12 months grew +13.0%, against +13.1% a year over the last 8 quarters (stabilising); profit over the last 12 months grew +7.7%, against +9.7% a year (stabilising).
How much of every ₹100 of sales does Shivalik Rasayan keep?
Shivalik Rasayan Ltd's operating margin was 14.7% in the Sep 2026 quarter, 1.9 percentage points higher than the same quarter a year ago. Across 12 years it has been between 7.3% and 21.9%. The latest quarter is within that range.
Operating margin is what is left from every ₹100 of sales after the costs of running the business, before interest and tax. It shows pricing power and cost control.
Why the margin moved: operating margin changed +1.9 percentage points on the year while gross margin changed +0.4 points. So the gain came mostly from costs below the gross margin, such as staff and overheads, measured against sales.
Is Shivalik Rasayan's profit turning into cash?
Over the last 3 years Shivalik Rasayan Ltd's operations used more cash than they brought in, so cash conversion was −88%, a gap worth watching. In FY26 its operations used ₹34.0 Cr of cash, against ₹18.0 Cr of profit. After ₹17.0 Cr of spending on assets, free cash was −₹51.0 Cr: it spent more than its operations brought in.
The profit and loss account shows what was earned. The cash-flow statement shows the cash that actually came in. Comparing operating cash flow with profit is one of the best checks that a profit is real.
Cash-flow figures here are yearly, because quarterly cash statements are not published, so this section changes once a year.
Why −88% of profit came in as cash: the cash cycle got 235 days longer between FY21 and FY26, so more of each rupee of profit waits in the business before it arrives. When less than 70% of profit comes in as cash, it is the thing to watch on this page.
What to look at next: less of the profit turns into cash than it should, and the cash cycle is 235 days longer. The next section looks at where the cash is stuck.
Where does Shivalik Rasayan's cash go?
Shivalik Rasayan Ltd's cash cycle, the days between paying suppliers and getting paid by customers, was 244 days in FY26, up from 9 days in FY21. It spent ₹108 Cr on assets over the last 3 years. Customers take 114 days to pay, and stock sits for 285 days on average.
Working capital is the cash tied up between paying suppliers and getting paid. Debtor days: how long customers take to pay. Inventory days: how long stock sits. The cash cycle: the whole loop, in days of sales.
At FY26 sales of ₹368 Cr, each day of that cycle ties up about ₹1.0 Cr, so roughly ₹246 Cr is tied up in the business at any time.
FY26: customers took 114 days to pay and stock sat for 285 days, about 9.4 months of sales sitting as stock, for a full cycle of 244 days, longer than FY21's 9.
The full loop: cash goes out to suppliers and production on day 0. Stock sits for 285 days. Customers pay about 114 days after that. Suppliers are paid at 155 days. Together that makes the 244-day cycle.
Spending on assets: ₹108 Cr over the last 3 years, against ₹47.0 Cr of depreciation (the yearly wear and tear on existing assets). So it is building well beyond replacing what wears out. Work still in progress is ₹0.0 Cr (FY26): assets paid for that are not earning yet.
In short: cash is getting stuck in the daily cycle, so watch the cycle more than the profit.
What is Shivalik Rasayan's P/E ratio, and how does it compare with its own history?
Shivalik Rasayan Ltd's P/E is 32.2×, near the low end of its own history: it has been lower only 32% of the time. Its usual P/E (the middle reading) is 41.0×, over 11 years of weekly prices. This compares the share price with the company’s own past. It does not say what the business is worth.
P/E is the share price divided by a year's profit per share: how many rupees the market pays for each rupee of yearly profit.
The P/E here, and its history, use a profit figure that can leave out one-off items, so it can differ from a P/E worked out on the quarterly results. Those results' earnings per share for the four quarters to Sep 2026 add up to ₹9.05.
Why the multiple is where it is: over the past year earnings per share moved +0.9% while the price moved −28.1%. Earnings did better than the price, which pulled the multiple down within its own range.
Where the price move came from: over 5 years the price moved −20.0% a year; about −12.8% a year came from earnings growth and about −7.2 percentage points from the multiple (the market paying less); over 10 years the price moved +12.1% a year; about −3.2% a year came from earnings growth and about +15.3 percentage points from the multiple (the market paying more). The split is approximate (price return minus earnings growth). It shows how much of the move came from the market paying a different multiple.
In short: the multiple is low against its own past, so the earnings trend underneath matters more than the multiple.
A quarterly PEG curve, which only the second data source has, is not shown on this page: its two data sources disagree by up to 31% on reported income across 15 comparable periods. When two sources disagree on a figure, we leave it out on purpose. The gap is a choice, not missing data.
Is the Shivalik Rasayan business getting better or worse?
Shivalik Rasayan Ltd's business is giving mixed signals. Growth has been steadily positive, but ROCE at 4.9% (four quarters to Sep 2026) is below the 15% level needed to call it steady growth. This is based on 9 quarters of 4 measures, with some gaps.
Every business is somewhere on a path of getting better or worse, and this section names where. The last 12 quarters of growth in revenue, profit and earnings per share, plus the return the business earns on its capital, are read as lines. Getting worse: the lines are falling. Turning around: a low point has just formed and the last few quarters are rising from it. Getting better: the rise from the low has lasted. Growing steadily: steady growth with healthy returns. Slowing from a peak: still high, but slowing. When the lines disagree the result is mixed; too little history means no reading. CAGR (compound annual growth rate) is the steady yearly rate that would turn the starting value into the latest one. It is the fairest way to compare growth over different periods. If the 1-year figure is much bigger than the 10-year one, recent growth is running faster than the long-run trend. A dash means there is no figure for that period, or the starting year was a loss, where a growth rate means nothing.
Why it matters: when the lines disagree, each line above matters more than any single label.
The return figures here are yearly, not quarterly. They show level and direction only; they can support the growth lines but never decide the reading alone.
This reading has some gaps: at least one line is short, or the return line is not the quarterly series, so treat it with a little more caution.
Compound annual growth rate (%)
Compound annual growth rate over each period, %. Revenue, profit and EPS come from yearly figures; the share price row is price growth over the same periods. A dash means no figure for that period, or the starting year was a loss.
| Measure | 1yr | 3yr | 5yr | 10yr |
|---|---|---|---|---|
| Revenue | +17.9% | +16.3% | +13.2% | +12.8% |
| Profit | −18.2% | −15.7% | −6.4% | +19.6% |
| EPS | −25.8% | −18.1% | −9.2% | +8.0% |
| Share price | −28.1% | −23.8% | −20.0% | +12.1% |
How much does Shivalik Rasayan earn on its capital?
Shivalik Rasayan Ltd earned a ROCE of 5% in FY26. We cannot compare its return on capital used with its cost of capital from the data we have. It comes from a 4.9% net margin and 0.45× asset turnover (sales divided by assets).
Return on capital employed (ROCE) is the profit the whole business earns on all the money in it, from shareholders and lenders together. It is the best single test of whether growth adds value or just size.
Why the return is what it is (FY26): a 4.9% net margin × 0.45× asset turnover × 1.37× leverage (assets divided by equity) ≈ 3.0% on equity. The margin does its share; borrowing plays a small part, so this return is earned, not borrowed.
The quarterly return lines and the return-on-capital-used (ROIC) line, which only the second data source has, are not shown on this page: its two data sources disagree by up to 31% on reported income across 15 comparable periods. When two sources disagree on a figure, we leave it out on purpose. The gap is a choice, not missing data.
Does Shivalik Rasayan have too much debt?
Shivalik Rasayan Ltd had ₹123 Cr of borrowings against ₹599 Cr of equity in FY26, so its debt is 0.21× its equity. Its operating profit is 4 times its interest bill. Over 5 years borrowings went from ₹29.0 Cr to ₹123 Cr. Over the last 3 of those years it spent ₹108 Cr on assets.
Debt-to-equity shows how much of the business is paid for with borrowed money. Interest cover shows how many times operating profit pays the interest bill. Low debt and high cover are the safe combination.
Part of the spending on assets is being paid for with borrowed money.
The total-debt and debt-to-equity series, which only the second data source has, are not shown on this page: its two data sources disagree by up to 31% on reported income across 15 comparable periods. When two sources disagree on a figure, we leave it out on purpose. The gap is a choice, not missing data.
What is the Shivalik Rasayan shareholding pattern?
Foreign institutions cut their stake in Shivalik Rasayan Ltd by 2.6 percentage points over 8 quarters, the biggest change among its owners. Foreign institutions now own 0.7% of the company. Promoters moved −1.4 points over the same period, to 46.5%. This uses the four owner groups that companies report every quarter; nothing is guessed between filings.
Who owns the company each quarter: promoters (the founders or controlling owners), foreign institutions, domestic institutions such as mutual funds, and the public. When people close to the business steadily raise their stake, that is worth noticing; a quiet list is also an answer.
Over the last two years: Foreign institutions: −2.6 points over 8 quarters, to 0.7%; Promoters: −1.4 points over 8 quarters, to 46.5%; Domestic institutions: −0.9 points over 8 quarters, to 0.0%.
Why the owners changed: foreign institutions drove it (−2.6 points), together with promoters (−1.4 points). They reduced their stake.
How far is Shivalik Rasayan from balance-sheet trouble?
For Shivalik Rasayan Ltd, the Z-score is not available, so we say so rather than guess one. It estimates how far the balance sheet is from trouble; it is not a forecast of failure. The debt, cash-flow and return sections show the balance-sheet figures we do have, each with its own date.
The Z-score estimates how far a company is from balance-sheet trouble. Above about 3 is safe; below about 1.8 is the danger zone. It was built for manufacturers, so it is not used for banks and lenders.
How does Shivalik Rasayan rank in its industry?
47.9 out of 100, rank 14 of 25 in Pesticides/Agrochemicals, with 67% of the evidence available.
Shivalik Rasayan Ltd scores 47.9 out of 100 against the 25 companies it is compared with in Pesticides/Agrochemicals, ranking 14. The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer.
The four parts add up to the total exactly: 19.7 + 9.5 + 7.7 + 11 = 47.9. This is the same number shown on the industry page; it is worked out once for the whole group and read here.
What would change it: The score would fall if profit growth turns negative or margins stop improving while the share price lags its sector.
Which companies is Shivalik Rasayan compared with?
Shivalik Rasayan ranks 14 of 25 Pesticides/Agrochemicals companies on the 4-Factor Sector Score, with 47.9 out of 100.
- 1Titan Biotech Ltdbreaking out · Most evidence points up · 87% evidence76.6out of 100
How the score adds up
Growth & earnings 31.3/35 · Revenue 31.8% · Profit 38.7% · Operating margin change 3 points · 95% evidenceCapital efficiency 21.3/25 · ROCE 22.8% (year to Mar 2026) · Operating margin 19.7% · 95% evidenceValuation 5.4/20 · P/E 55.2× · PEG — · 50% evidenceRelative strength 18.6/20 · Strength vs its industry (price vs its 52-week average, weekly) 44.3% · Strength vs NIFTY 500 (same reading) 21.3% · 1 year 177.2% · 100% evidence · 4 of 12 weeks aheadExact sum: 31.3 + 21.3 + 5.4 + 18.6 = 76.6 · What this means: Earnings, capital efficiency and relative strength all agree. The open questions are about management, upcoming events and risks. - 2Sharda Cropchem LtdSHARDACROP · basing · Most evidence points up · 100% evidence66.9out of 100
How the score adds up
Growth & earnings 28.2/35 · Revenue 17.3% · Profit 42.5% · Operating margin change 2 points · 100% evidenceCapital efficiency 19.6/25 · ROCE 30.2% (year to Mar 2026) · Operating margin 15.6% · 100% evidenceValuation 11.5/20 · P/E 9.8× · PEG 2.26 · 100% evidenceRelative strength 7.6/20 · Strength vs its industry (price vs its 52-week average, weekly) -5.2% · Strength vs NIFTY 500 (same reading) -21.1% · 1 year -12.6% · 100% evidence · 0 of 12 weeks aheadExact sum: 28.2 + 19.6 + 11.5 + 7.6 = 66.9 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. - 3Jubilant Ingrevia LtdJUBLINGREA · quiet · Most evidence points up · 93% evidence65.3out of 100
How the score adds up
Growth & earnings 27.4/35 · Revenue 15.4% · Profit 21.9% · Operating margin change 3 points · 100% evidenceCapital efficiency 13.8/25 · ROCE 11.4% (year to Mar 2026) · Operating margin 15.2% · 100% evidenceValuation 12.9/20 · P/E 26.7× · PEG 1.16 · 65% evidenceRelative strength 11.2/20 · Strength vs its industry (price vs its 52-week average, weekly) 3.8% · Strength vs NIFTY 500 (same reading) -13.5% · 1 year -18.5% · 100% evidence · 2 of 12 weeks aheadExact sum: 27.4 + 13.8 + 12.9 + 11.2 = 65.3 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. - 4Bayer CropScience LtdBAYERCROP · quiet · Evidence leans up · 85% evidence63.0out of 100
How the score adds up
Growth & earnings 24.5/35 · Revenue -5% · Profit 22.5% · Operating margin change 4 points · 100% evidenceCapital efficiency 19.3/25 · ROCE 29.1% (year to Mar 2026) · Operating margin 17.4% · 100% evidenceValuation 10.6/20 · P/E 20.2× · PEG 2.21 · 100% evidenceRelative strength 8.6/20 · Strength vs its industry (price vs its 52-week average, weekly) — · Strength vs NIFTY 500 (same reading) -22.1% · 1 year -26.2% · 25% evidence · 0 of 12 weeks aheadExact sum: 24.5 + 19.3 + 10.6 + 8.6 = 63 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. - 5Dhanuka Agritech LtdDHANUKA · quiet · Evidence leans up · 100% evidence54.7out of 100
How the score adds up
Growth & earnings 10.0/35 · Revenue 0% · Profit 0.7% · Operating margin change 0 points · 100% evidenceCapital efficiency 19.8/25 · ROCE 25.9% (year to Mar 2026) · Operating margin 23.3% · 100% evidenceValuation 11.4/20 · P/E 14.8× · PEG 2.07 · 100% evidenceRelative strength 13.5/20 · Strength vs its industry (price vs its 52-week average, weekly) 0.8% · Strength vs NIFTY 500 (same reading) -16.1% · 1 year -23.7% · 100% evidence · 0 of 12 weeks aheadExact sum: 10 + 19.8 + 11.4 + 13.5 = 54.7 · What this means: Relative strength against the index is -16.1%, and revenue and profit growth are weak. - 6Advance Agrolife LtdADVANCE · losing its lead · Evidence leans up · 68% evidence54.7out of 100
How the score adds up
Growth & earnings 19.0/35 · Revenue 49.4% · Profit 55.2% · Operating margin change -4 points · 100% evidenceCapital efficiency 13.7/25 · ROCE 19.6% (year to Mar 2026) · Operating margin 7.7% · 100% evidenceValuation 10.1/20 · P/E 17.4× · PEG — · 15% evidenceRelative strength 11.9/20 · Strength vs its industry (price vs its 52-week average, weekly) — · Strength vs NIFTY 500 (same reading) 2.3% · 1 year -8.5% · 25% evidence · 10 of 12 weeks aheadExact sum: 19 + 13.7 + 10.1 + 11.9 = 54.7 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. - 7Punjab Chemicals & Crop Protection LtdPUNJABCHEM · quiet · Evidence leans up · 75% evidence53.0out of 100
How the score adds up
Growth & earnings 19.6/35 · Revenue 14% · Profit 13.2% · Operating margin change -1 points · 100% evidenceCapital efficiency 13.2/25 · ROCE 18.6% (year to Mar 2026) · Operating margin 9.2% · 100% evidenceValuation 11.0/20 · P/E 17.9× · PEG — · 50% evidenceRelative strength 9.2/20 · Strength vs its industry (price vs its 52-week average, weekly) — · Strength vs NIFTY 500 (same reading) -19% · 1 year -34.1% · 25% evidence · 3 of 12 weeks aheadExact sum: 19.6 + 13.2 + 11 + 9.2 = 53 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. - 8Dharmaj Crop Guard LtdDHARMAJ · quiet · Evidence leans up · 75% evidence52.4out of 100
How the score adds up
Growth & earnings 14.5/35 · Revenue 3.8% · Profit 14.3% · Operating margin change -2 points · 100% evidenceCapital efficiency 14.7/25 · ROCE 16.8% (year to Mar 2026) · Operating margin 7.2% · 100% evidenceValuation 13.2/20 · P/E 15.1× · PEG — · 50% evidenceRelative strength 10.0/20 · Strength vs its industry (price vs its 52-week average, weekly) — · Strength vs NIFTY 500 (same reading) -9.7% · 1 year -0.9% · 25% evidence · 5 of 12 weeks aheadExact sum: 14.5 + 14.7 + 13.2 + 10 = 52.4 · What this means: The valuation scores well, but earnings are not improving yet, so the business does not back up the low multiple so far. - 9Best Agrolife LtdBESTAGRO · quiet · Evidence leans up · 90% evidence52.0out of 100
How the score adds up
Growth & earnings 24.7/35 · Revenue -19.6% · Profit 100% · Operating margin change 10 points · 100% evidenceCapital efficiency 10.0/25 · ROCE 5.2% (year to Mar 2026) · Operating margin 24.8% · 100% evidenceValuation 11.3/20 · P/E 10.8× · PEG — · 50% evidenceRelative strength 6.0/20 · Strength vs its industry (price vs its 52-week average, weekly) -4.7% · Strength vs NIFTY 500 (same reading) -20.8% · 1 year -26.5% · 100% evidence · 7 of 12 weeks aheadExact sum: 24.7 + 10 + 11.3 + 6 = 52 · What this means: Earnings are strong; relative strength in its sector is -4.7% and the one-year return is -26.5%. - 10Meghmani Organics LtdMOL · quiet · Evidence leans down · 68% evidence49.7out of 100
How the score adds up
Growth & earnings 20.9/35 · Revenue -5.2% · Profit 100% · Operating margin change 2 points · 100% evidenceCapital efficiency 7.7/25 · ROCE 6.7% (year to Mar 2026) · Operating margin 10.9% · 100% evidenceValuation 10.4/20 · P/E 15.6× · PEG — · 15% evidenceRelative strength 10.7/20 · Strength vs its industry (price vs its 52-week average, weekly) — · Strength vs NIFTY 500 (same reading) -2.3% · 1 year -23.9% · 25% evidence · 8 of 12 weeks aheadExact sum: 20.9 + 7.7 + 10.4 + 10.7 = 49.7 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. - 11Excel Industries LtdEXCELINDUS · losing its lead · Evidence leans down · 68% evidence49.0out of 100
- 12UPL LtdUPL · basing · Evidence leans down · 82% evidence48.9out of 100
- 13Rallis India LtdRALLIS · quiet · Evidence leans down · 85% evidence47.9out of 100
- 14Shivalik Rasayan Ltd this pageSHIVALIK · turning · Evidence leans down · 67% evidence47.9out of 100
How the score adds up
Growth & earnings 19.7/35 · Revenue 13% · Profit 7.7% · Operating margin change 1.9 points · 95% evidenceCapital efficiency 9.5/25 · ROCE 4.8% (year to Mar 2026) · Operating margin 14.8% · 76% evidenceValuation 7.7/20 · P/E 32.2× · PEG — · 50% evidenceRelative strength 11.0/20 · Strength vs its industry (price vs its 52-week average, weekly) — · Strength vs NIFTY 500 (same reading) -1% · 1 year -28.1% · 25% evidence · 1 of 1 week aheadExact sum: 19.7 + 9.5 + 7.7 + 11 = 47.9 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. - 15Bhagiradha Chemicals & Industries LtdBHAGCHEM · quiet · Evidence leans down · 83% evidence47.7out of 100
- 16Epigral LtdEPIGRAL · quiet · Evidence leans down · 75% evidence46.8out of 100
- 17India Pesticides LtdIPL · quiet · Evidence leans down · 75% evidence46.0out of 100
- 18Sumitomo Chemical India LtdSUMICHEM · quiet · Evidence leans down · 85% evidence43.7out of 100
- 19Insecticides India LtdINSECTICID · quiet · Evidence leans down · 90% evidence42.8out of 100
- 20Bharat Rasayan LtdBHARATRAS · basing · Evidence leans down · 90% evidence42.4out of 100
- 21GSP Crop Science LtdGSPCROP · quiet · Evidence leans down · 63% evidence39.8out of 100
- 22P I Industries LtdPIIND · quiet · Most evidence points down · 75% evidence34.5out of 100
- 23NACL Industries LtdNACLIND · basing · Most evidence points down · 90% evidence32.9out of 100
- 24Heranba Industries LtdHERANBA · quiet · Most evidence points down · 71% evidence31.9out of 100
- 25Astec Lifesciences LtdASTEC · quiet · Most evidence points down · 71% evidence31.3out of 100
Missing figures are not scored as bad. They lower the confidence and pull the final score toward the middle. Relative strength counts only when the company has a reading for this week; with no reading, that factor is left out and its 20 points are shared across the other three in proportion. PEG is not shown when the ratio cannot mean anything: the company must be making a profit, its price-to-earnings must be positive, and its three-year earnings growth must fall between 5% and 60%. Dividing a price multiple by a loss, or by growth measured off a tiny base, produces a number that looks precise and tells you nothing. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led NIFTY 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step path the industry is placed on (basing, turning, breaking out, leader, fading, asleep), read from how many weeks running it has led NIFTY 500 and whether that lead is growing or shrinking. It describes where the share price stands, not the direction of earnings, and it is not a recommendation; it is left blank for a company whose weekly history is too short or too stale to read.
In this ranking every company's P/E uses its own latest official close and its last four filed quarters, the same rule as the top of this page. ROCE here is each company's last full year, as labelled, so it can differ from the four-quarter ROCE above. The stage words in this ranking (such as losing its lead or breaking out) describe the lead over the index, not the price phase in the price section.
Related companies: Pesticides/Agrochemicals, all 25 compared on one page.
Which companies are close to Shivalik Rasayan in size?
Shivalik Rasayan is the 25th largest of 25 Pesticides/Agrochemicals companies on Sector Alpha by market value (at the 18 November 2026 close). Just above it: Astec Lifesciences, Punjab Chemicals & Crop Protection, Dharmaj Crop Guard, Advance Agrolife, Heranba Industries and Best Agrolife. It is the smallest.
Pesticides/Agrochemicals companies close in size
- Astec Lifesciences Ltd ₹1,222 crore
- Punjab Chemicals & Crop Protection Ltd ₹1,080 crore
- Dharmaj Crop Guard Ltd ₹847 crore
- Advance Agrolife Ltd ₹777 crore
- Heranba Industries Ltd ₹583 crore
- Best Agrolife Ltd ₹521 crore
- Shivalik Rasayan Ltd ₹467 crore
All 25 Pesticides/Agrochemicals companies, largest first
Companies close in size in other industries
- Oswal Agro Mills Ltd ₹468 crore · Trading
- Niyogin Fintech Ltd ₹467 crore · Finance & Investments - Others
- Shivalik Rasayan Ltd ₹467 crore
- Shish Industries Ltd ₹466 crore · Plastics - Sheets/Films
- Committed Cargo Care Ltd ₹466 crore
What else do people ask about Shivalik Rasayan?
What were Shivalik Rasayan's latest quarterly results?
Shivalik Rasayan Ltd reported revenue of ₹101 Cr and net profit of ₹5.4 Cr for the Sep 2026 quarter. Revenue rose 7.2% and profit rose 25.3% compared with a year earlier. Earnings per share were ₹2.30.
The operating margin was 14.7%, 1.9 percentage points higher than a year earlier (as of 18 November 2026).
What is Shivalik Rasayan's market cap?
Shivalik Rasayan Ltd's market capitalisation is ₹467 Cr at a share price of ₹291.20. Market cap is the share price times the number of shares, so it changes whenever the price moves (as of 18 November 2026).
How is Shivalik Rasayan performing?
Shivalik Rasayan Ltd's share price is in an uptrend that has just slipped below its 200-day average. In its latest quarter, revenue rose 7.2% and profit rose 25.3% compared with a year earlier.
Over the past 13 weeks it has done worse than the NIFTY 500, for 2 weeks running (as of 18 November 2026).
Will Shivalik Rasayan's share price go up?
This page does not forecast Shivalik Rasayan Ltd's share price. What it shows instead: the share price is ₹291.20, and it has been rising for 7 weeks. Its P/E of 32.2× is higher than 32% of its own last 11 years (as of 18 November 2026).
Who owns Shivalik Rasayan?
Promoters own 46.5% of Shivalik Rasayan Ltd, foreign institutions 0.7%, domestic institutions 0.0% and the public 52.7% (latest quarter). The biggest change over the last two years: Foreign institutions cut their stake by 2.6 percentage points over 8 quarters (as of 18 November 2026).
Does Shivalik Rasayan have too much debt?
No, Shivalik Rasayan Ltd has little debt: its debt is 0.17× its equity, and its operating profit is 3 times its interest bill. At Sep 2026 borrowings were ₹107 Cr against equity of ₹621 Cr.
So the returns on this page come from the business, not borrowed money (as of 18 November 2026).
Where is Shivalik Rasayan in its business cycle?
Shivalik Rasayan Ltd's FY26 operating margin was 12.8%, against a 12-year range of 7.3% to 21.9%. The latest quarter was 14.7%, the middle of its own range, neither a peak nor a low.
Comparing margins with a company's own long history is a good way to see where it is in its cycle (as of 18 November 2026).
What could break the Shivalik Rasayan story?
The main question: profits are rising, but only −88% of the last 3 years' profit came in as cash from operations. The gap between reported profit and actual cash is the thing to watch.
On price, this page treats a rise as over when the share price closes below its 200-day average on two Fridays in a row (as of 18 November 2026).
Is Shivalik Rasayan a stock worth studying right now?
What the numbers show: Shivalik Rasayan Ltd's results are improving, while its P/E is near the low end of its own history over 11 years, higher than only 32% of past readings. The main open question: whether the cash starts to follow the profit.
Every number on this page is worked out by code from the published figures, with no forecasts and no price opinions (as of 18 November 2026).
Where do these numbers come from?
Sector Alpha, written by code from the published numbers. Data as of 18 November 2026.
Every chart on this page is drawn by code from the published figures, with no forecasts and no price opinions.
See the plain-text version of this page.
More lists
Every Sector Alpha list, grouped
Stock screens
Market lists
Themes
Sectors
X · Instagram · YouTube · About · Newsletter · Newsletter archive
This is research, not advice. We’re not SEBI-registered.